From our CEO
26 June 2024
In his speech at the National Summit on Neurological Conditions, MS Australia CEO and NAA Chair calls for greater action to support people living with neurological conditions.
In his speech at the National Summit on Neurological Conditions, MS Australia CEO and NAA Chair calls for greater action to support people living with neurological conditions.
A new study has explored low intensity rTMS as a treatment for MS, revealing high compliance and laying the groundwork for future breakthroughs.
For over 30 years, travel agent Lois Marshall has helped people explore new horizons. But her particular journey extends beyond travel — it’s about making a difference for people with multiple sclerosis.
Australian researchers have identified a brain region that enlarges over time in people with relapsing-remitting MS and correlates with the expansion of chronic lesions and nerve damage.
Australian researchers have found a link between COVID-19-related hardships and reduced quality of life.
LEEP member Kate shares her story of MS diagnosis for MS Australia’s World MS Day 2024 advocacy. The 2024-2025 theme ‘My MS Diagnosis’, advocates for timely and accurate identification of MS.
A new report has revealed the prolonged time to diagnose multiple sclerosis (MS) and highlighted the urgent need for increased investment in MS research and enhanced awareness of the disease.
Sarah Flaim is a member of the Lived Experience Expert Panel (LEEP), which brings a wide range of lived experience and expertise to the work of MS Australia.
Jessica Worsley is a member of the Lived Experience Expert Panel (LEEP), which brings a wide range of lived experience and expertise to the work of MS Australia.